US · USD
IBRX
Immunitybio Inc
- Day's range
- $10.13 – $10.81
- Day's volume
- $143.7M
- 52-week range
- $1.98 – $11.55
Follow IBRX in the Fuolio
See how IBRX weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountIBRX in numbers
- Market cap
- $10.8B
- P/E
- -11.08
- P/B
- -10.51
- Dividend yield (12m)
- 0.00%
IBRX price history
IBRX risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +336.65% | +180.03% | +32.28% |
| Volatility (annualized) | 223.00% | 146.92% | 128.65% |
| Largest drawdown | -27.40% | -75.22% | -79.33% |
| Positive months | 8/12 | 16/36 | 28/60 |
How much did investing in IBRX return?
$1,000.00 invested on 11/01/2021 would be worth $1,332.48 today.
- Value today in IBRX
- $1,332.48
- Return over the period
- +33.25%
- Return per year
- +6.00%
- In the S&P 500
- $1,702.20
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
IBRX fundamentals
Valuation
- P/E-11.08
- P/B-10.51
- EV/EBITDA-46.05
- EV/EBIT-43.02
- EV/Revenue65.33
- P/EBIT-43.02
- P/S65.33
- P/OCF-38.53
- P/FCF-37.60
- Earnings yield-2.32%
- PEG ratio—
- Earnings per share-$0.94
- Book value per share-$0.99
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio5.72
- Quick ratio5.70
- Cash ratio4.66
Efficiency
- Gross margin99.34%
- EBITDA margin-141.86%
- Operating margin-151.88%
- Net margin-598.62%
- Asset turnover0.26
Profitability
- ROE94.82%
- ROA-157.91%
- ROIC—
- Payout—
Growth
- Revenue CAGR (5 years)202.92%
- Earnings CAGR (5 years)—
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
IBRX's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | -5.79 | -5.28 | -5.79 | -5.30 | -6.92 | -6.57 | -2.37 | -0.95 |
| P/B | -4.07 | -4.47 | -5.76 | -4.94 | -9.99 | -12.17 | 22.86 | 1.12 |
| Earnings per share | -$0.34 | -$0.48 | -$0.87 | -$0.96 | -$0.88 | -$2.03 | -$1.60 | -$1.22 |
| Book value per share | -$0.49 | -$0.57 | -$0.87 | -$1.03 | -$0.61 | -$1.10 | $0.17 | $1.04 |
| ROE | 70.23% | 84.56% | 99.47% | 93.29% | 144.44% | 185.17% | -966.42% | -117.43% |
| ROIC | — | — | — | — | — | — | -956.44% | -119.45% |
| Gross margin | 99.34% | 100.00% | 100.00% | 100.00% | — | — | — | — |
| EBITDA margin | -212.29% | -2,215.18% | -55,263.34% | -138,765.83% | -33,837.47% | -34,403.47% | -6,458.17% | -189,008.51% |
| Net margin | -310.27% | -2,805.02% | -93,874.60% | -173,875.00% | -37,451.82% | -36,669.59% | -7,165.17% | -204,736.17% |
IBRX's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $113.3M | $14.7M | $622K | $240K | $934K | $605K |
| Cost of revenue | -$753K | $0 | $0 | $0 | — | — |
| Gross profit | $112.5M | $14.7M | $622K | $240K | — | — |
| EBITDA | -$240.5M | -$326.6M | -$343.7M | -$333M | -$316M | -$208.1M |
| EBIT | -$256M | -$344.2M | -$362.3M | -$351.3M | -$330.3M | -$220.9M |
| Financial result | -$95.6M | -$69.5M | -$221.6M | -$66M | -$19.6M | -$5.2M |
| Income before tax | -$351.6M | -$413.6M | -$583.9M | -$417.3M | -$349.8M | -$226M |
| Income tax | $135K | $0 | $40K | -$34K | -$9K | $1.8M |
| Net income | -$351.5M | -$413.6M | -$583.9M | -$417.3M | -$349.8M | -$221.9M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does IBRX pay dividends?
IBRX has no distributions on record.
About Immunitybio
- Sector
- Manufacturing
Questions about IBRX
How much is IBRX today?
IBRX is at $10.38 (0.92% on the day), last traded on 10/05/2026.
What are the P/E and P/B of IBRX?
IBRX trades at a P/E of -11.08 and a P/B of -10.51.
How much did IBRX return in 12 months?
IBRX returned 336.65% in 12 months, with annualized volatility of 223.00% and a largest drawdown of -27.40%.